Loading EFTA-India Explorer...
Loading EFTA-India Explorer...
This platform converts TEPA from a treaty text into a practical commercial workflow: product benefit discovery, origin-readiness review, document readiness, partner routing, shipment preparation, finance readiness, market-entry support and controlled opportunity execution.
India and EFTA partner markets
Explore product, service, investment, procurement, technology, regulated-product and market-entry opportunities connected to the EFTA-India corridor. Choose the opportunity path that matches your objective, then continue to the relevant eligibility, readiness or controlled execution workflow.
Select one direction to keep opportunity, readiness and execution routing separate.
Explore exports, services, investment, acquisitions, procurement, technology cooperation and market entry in Switzerland, Norway, Iceland and Liechtenstein.
Explore Indian investment, manufacturing, joint ventures, technology transfer, procurement, distribution, regulated products and controlled execution.
Use this direction for exports, services access, investment and acquisition opportunities, procurement, technology cooperation, regulated-product readiness and controlled execution across Switzerland, Norway, Iceland and Liechtenstein.
Opportunity access, treaty benefit, origin, regulatory readiness, partner routing and execution remain subject to the applicable official requirements and platform manual review.
Find the product and establish its HS context for exports from India before reviewing EFTA tariff commitments, origin requirements and possible treaty benefits.
Review services access, establishment, professional mobility, licensing and other non-goods pathways for Switzerland, Norway, Iceland and Liechtenstein.
Review investment, acquisition, joint-venture, participation and market-entry readiness for Indian companies and investors entering EFTA markets.
Explore procurement participation in EFTA markets while preserving authority rules, tender eligibility, evidence requirements and manual review.
Review regulatory, clinical, quality, import and documentary readiness for pharmaceutical and medical-device entry into the four EFTA countries.
Review intellectual-property protection, licensing, technology cooperation and evidence readiness for Indian activity across EFTA markets.
Review sustainability, traceability, responsible-production and governance readiness relevant to Indian goods, services and investments entering EFTA markets.
Continue from directional opportunity discovery into company intelligence, finance readiness, institutional participation, partner routing and platform-mediated execution. Access remains manual-review-only.
Review company portfolios, market intelligence and ongoing EFTA-India commercial changes.
Prepare finance readiness, evidence-reviewed status, institutional participation and corridor capability.
Move from reviewed opportunity context into platform-mediated investment, partner and execution workflows.
Review EFTA-India access plans for free discovery, paid review, company portfolios and enterprise participation.
Use the official TEPA duty-benefit workflow to identify whether a product may benefit from preferential treatment route by route.
A tariff benefit is only useful if the origin evidence, product-specific rule and supporting documents are ready for manual review.
The platform connects benefit discovery to document pack, finance readiness, partner routing, shipment readiness and counterparty checks.
TEPA is used as the entry point for product passport, investment readiness, partner matching, market insights and execution support.
Official treaty families connected to the EFTA corridor explorer.